c-Met inhibitor 1 structure
|
Common Name | c-Met inhibitor 1 | ||
|---|---|---|---|---|
| CAS Number | 1357072-61-7 | Molecular Weight | 362.412 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C17H14N8S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of c-Met inhibitor 1c-Met inhibitor 1 is an inhibitor of the c-Met receptor signaling pathway useful for the treatment of cancer including gastric, glioblastoma, and pancreatic cancer. IC50 value:Target: c-MetMore details please refer to Patent WO 2012015677 A1. |
| Name | 3-(2-methylindazol-5-yl)sulfanyl-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine |
|---|---|
| Synonym | More Synonyms |
| Description | c-Met inhibitor 1 is an inhibitor of the c-Met receptor signaling pathway useful for the treatment of cancer including gastric, glioblastoma, and pancreatic cancer. IC50 value:Target: c-MetMore details please refer to Patent WO 2012015677 A1. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Molecular Formula | C17H14N8S |
| Molecular Weight | 362.412 |
| Exact Mass | 362.106201 |
| PSA | 104.02000 |
| LogP | 2.46 |
| Index of Refraction | 1.838 |
| Storage condition | 2-8℃ |
| FD5012 |
| 3-[(2-Methyl-2H-indazol-5-yl)sulfanyl]-6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazine |
| 6-(1-METHYL-1H-PYRAZOL-4-YL)-3-((2-METHYL-2H-INDAZOL-5-YL)THIO)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE |
| 1,2,4-Triazolo[4,3-b]pyridazine, 3-[(2-methyl-2H-indazol-5-yl)thio]-6-(1-methyl-1H-pyrazol-4-yl)- |
| c-Met inhibitor 1 |